NNNN ANBIO BIOTECHNOLOGY: institutional ownership and insider trading
12 funds reported holding $985K of ANBIO BIOTECHNOLOGY in their latest 13F filings; in Q2 2026 funds net bought $297K, with 6 new positions and 2 funds selling out.
Largest institutional holders of NNNN
- GEODE CAPITAL MANAGEMENT, LLC — $367K
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $184K
- BNP PARIBAS FINANCIAL MARKETS — $162K
- MARSHALL WACE, LLP — $158K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $99.1K
- UBS Group AG (UBS) — $11.4K
- EverSource Wealth Advisors, LLC — $2.56K
- OSAIC HOLDINGS, INC. — $1.06K
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $718
- Bare Financial Services, Inc — $206